Aclarion, Inc. Common Stock (ACON) is a publicly traded Healthcare sector company. As of May 21, 2026, ACON trades at $3.14 with a market cap of $7.88M and a P/E ratio of -0.36. ACON moved +2.19% today. Year to date, ACON is -38.42%; over the trailing twelve months it is -54.10%. Its 52-week range spans $2.34 to $3,499.51. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces ACON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes ACON SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $3.14 |
| Market Cap | $7.88M |
| P/E Ratio | -0.36 |
| EPS | $-9.03 |
| Dividend Yield | 0.00% |
| 52-Week High | $3,499.51 |
| 52-Week Low | $2.34 |
| Volume | 15 |
| Avg Volume | 0 |
| Revenue (TTM) | $77.88K |
| Net Income | $-8.05M |
| Gross Margin | 19.35% |
1 analysts cover ACON: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.